ATNM vs TOST · rev $35.0M vs P/E 161, rev $3.54B
Actinium Pharmaceuticals Inc (ATNM) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
ATNM currently screens at market cap $33.9M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the ATNM and TOST stock pages for the full models.
Not investment advice.